Skip to main content
  • SAPIEN 3 Bests Surgery in 'Intermediate Risk' Patients Outcomes better but rates of aortic regurgitation still favor surgery

    CHICAGO — Compared with a surgical strategy, transcatheter aortic valve replacement (TAVR) using the new generation Sapien 3 device was tied to fewer adverse outcomes in intermediate-risk patients, according to a propensity-score analysis.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details